Skip to main content

Addition of Durvalumab After Chemoradiotherapy Improves Progression-Free Survival in Unresectable Stage III Non-Small-Cell Lung Cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Addition of Durvalumab After Chemoradiotherapy Improves Progression-Free Survival in Unresectable Stage III Non-Small-Cell Lung Cancer

User login

Username

Password

Reset your password

Type	Lead	score